E-MAIL: [email protected]
Novo Nordisk has achieved a landmark victory with the FDA's approval of oral semaglutide for chronic weight management, marking the world's first oral GLP-1 receptor agonist specifically indic...
242025.12
FDA Approves Two Oral Therapies to Treat Gonorrhea
172025.12
Which Drugs Utilize Single-Use (Disposable) Injection Pens?
mg vs. IU in Injection Pens: Decoding the Two Languages of Drug Dosage
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
